CAM
CLX icon

Cresset Asset Management’s Clorox CLX Stock Holding History

Cresset Asset Management’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$344K Sell
3,604
-1,960
-35% -$188K ﹤0.01% 1321
2026
Q1 		$577K Sell
5,564
-30,759
-85% -$3.49M ﹤0.01% 1001
2025
Q4 		$3.66M Sell
36,323
-817
-2% -$88.7K 0.02% 425
2025
Q3 		$4.58M Buy
37,140
+800
+2% +$99.3K 0.02% 366
2025
Q2 		$4.36M Sell
36,340
-6,939
-16% -$926K 0.02% 353
2025
Q1 		$6.37M Buy
43,279
+10,924
+34% +$1.67M 0.03% 316
2024
Q4 		$5.25M Sell
32,355
-21,413
-40% -$3.5M 0.03% 341
2024
Q3 		$8.76M Sell
53,768
-757
-1% -$112K 0.03% 342
2024
Q2 		$7.44M Buy
54,525
+7,953
+17% +$1.1M 0.03% 349
2024
Q1 		$7.13M Buy
46,572
+16,980
+57% +$2.53M 0.03% 317
2023
Q4 		$4.22M Sell
29,592
-389
-1% -$51.9K 0.03% 381
2023
Q3 		$3.93M Buy
29,981
+2,033
+7% +$309K 0.02% 382
2023
Q2 		$4.44M Buy
27,948
+25,546
+1,064% +$4.12M 0.01% 443
2023
Q1 		$380K Buy
+2,402
New +$360K 0.01% 558
2022
Q4 		– Sell
-2,514
Closed -$323K – 766
2022
Q3 		$323K Sell
2,514
-656
-21% -$94.7K ﹤0.01% 648
2022
Q2 		$362K Buy
3,170
+902
+40% +$129K ﹤0.01% 653
2022
Q1 		$316K Sell
2,268
-14,553
-87% -$2.23M ﹤0.01% 761
2021
Q4 		$2.93M Buy
16,821
+5,130
+44% +$855K 0.03% 232
2021
Q3 		$1.94M Buy
11,691
+3,411
+41% +$587K 0.03% 240
2021
Q2 		$1.49M Buy
8,280
+2,805
+51% +$512K 0.02% 259
2021
Q1 		$1.06M Buy
5,475
+3,470
+173% +$668K 0.02% 287
2020
Q4 		$405K Buy
2,005
+220
+12% +$45.5K 0.01% 461
2020
Q3 		$376K Buy
1,785
+66
+4% +$14.7K 0.01% 444
2020
Q2 		$377K Buy
1,719
+466
+37% +$93.1K 0.01% 399
2020
Q1 		$217K Buy
+1,253
New +$207K 0.01% 489
2019
Q2 		– Sell
-118
Closed -$19K – 698
2019
Q1 		$19K Buy
118
+45
+62% +$6.98K ﹤0.01% 1024
2018
Q4 		$11K Buy
+73
New +$11.4K ﹤0.01% 831

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Cresset Asset Management's CLX Position: Q2 2026 in Review

Cresset Asset Management reduced its Clorox (CLX) stake by 35% in Q2 2026, selling an estimated $188K and leaving 3,604 shares worth $344K. The position accounts for ﹤0.01% of the portfolio, ranked #1321.

Cresset Asset Management first reported a position in CLX in Q4 2018 and has held it in 27 quarters since. The position peaked at $8.76M in Q3 2024. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Cresset Asset Management held 3,604 shares of Clorox worth $344K as of Q2 2026.
  • Cresset Asset Management sold 1,960 Clorox shares in Q2 2026, an estimated $188K.
  • Clorox made up ﹤0.01% of Cresset Asset Management's portfolio in Q2 2026, its #1321 holding.
  • Cresset Asset Management first reported a position in Clorox in Q4 2018 and has held it in 27 quarters since.
  • Cresset Asset Management's Clorox position peaked at $8.76M in Q3 2024.
  • 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.